BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 17, 2020
View Archived Issues
First multitope peptide-based vaccine against SARS-CoV-2 to enter clinical testing
Read More
Blood infrastructure problems contribute to ASD
Read More
Everyone's an immune cell
Read More
c-Myc overexpression used to create mouse-derived allograft model of hepatocellular carcinoma
Read More
SBIR grant supports Lamassu's development of RABI-767 for acute pancreatitis
Read More
Chinese clearance for global phase III trial of catumaxomab for peritoneal carcinomatosis
Read More
HFB-200301 shows potential as novel immunotherapeutic agent in vivo
Read More
BPI-28592, a novel potent next-generation TRK kinase inhibitor
Read More
Nexys Therapeutics presents new ALK5 inhibitors
Read More
Praxis Precision Medicines patents compounds targeting human KCNT1
Read More
SPRY1 targeting useful for treating BRAF V600-mutant cutaneous melanoma
Read More
Recce and Path BioAnalytics collaborate in expanded SARS-CoV-2 program
Read More
Surface Oncology describes preclinical activity of anti-PVRIG antibody SRF-813
Read More
Bcl-2/Bcl-xl dual inhibitor AZD-0466 shows promise for treating ALL
Read More
Heron initiates phase II GUARDS-1 study of Cinvanti for the treatment of COVID-19
Read More
Binding of MAO-A PET radiotracer [18F]FAZIN-3 observed in Parkinson's, Alzehimer's brain samples
Read More
NIH grant supports development of Vivasc's CTP-amio for arrhythmia
Read More
Dynavax and Mount Sinai collaborate to develop a universal influenza vaccine
Read More
Phase III trial begins in UAE for Sinopharm's inactivated vaccine for COVID-19
Read More
Xenleta approved in Canada for community-acquired pneumonia
Read More
Tracon files pivotal ENVASARC protocol with the FDA
Read More
Expansion of phase I study evaluating eprenetapopt in TP53-mutant AML
Read More
[18F]-FSPG PET can rule out cardiac sarcoidosis after nondiagnostic [18F]-FDG PET
Read More
Samus opens phase IIa trial of PU-AD for mild Alzheimer's disease dementia
Read More
Lilly reports OASIS-2 data with mirikizumab in moderate to severe plaque psoriasis
Read More
Celltrion advances antiviral antibody treatment for COVID-19 into phase I
Read More